Status:
UNKNOWN
Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy
Lead Sponsor:
Acibadem University
Conditions:
Duchenne Muscular Dystrophy
Eligibility:
MALE
7-20 years
Phase:
PHASE1
PHASE2
Brief Summary
Duchenne muscular dystrophy (DMD) is a genetic disorder caused by an absence of dystrophin and characterized by progressive muscle degeneration. There is no cure for DMD at present but, there are seve...
Eligibility Criteria
Inclusion
- \- Patients with diagnosis of DMD that is proven clinically and genetically Age between 7-20 Patients need partial respiratory support, during the day Patients have less than or equal to stage I NIH, Liver, renal and cardiac function Patients without cancer Patients without allergic disease Patients without bleeding diathesis,
Exclusion
- Patients need complete respiratory support Patients have more than to stage II NIH, Liver, renal and cardiac function Patients have bleeding diathesis and allergic disease
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02285673
Start Date
November 1 2013
End Date
November 1 2015
Last Update
November 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acibadem Labcell
Istanbul, Uskudar, Turkey (Türkiye), 34662